Document Detail


Optimization of the processing of matrix pellets based on the combination of waxes and starch using experimental design.
MedLine Citation:
PMID:  9876595     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An experimental design was used in order to optimize the one-step production process of matrix pellets based on the combination of waxes and starch. The parameters tested were the impeller speed (x1) and the mixing time (x2). Ibuprofen and theophylline were used as model drugs at a concentration of 60 and 70% (w/w), respectively. The 0.8-1.25 mm yield fraction of the matrix pellets was evaluated as the response factor Y. A quadratic equation was fitted to the experimental data and used to predict the response factor Y of the theophylline and the ibuprofen. The contour plots of both formulations revealed a flat and therefore rugged region from the upper left to the lower right of the domain investigated. The energy input into the system during the production process controlled the pellet growth, the impeller speed having a greater impact on the energy input compared to the mixing time.
Authors:
F Zhou; C Vervaet; D L Massart; B Massart; J P Remon
Related Documents :
21388605 - The theory of planned behavior as a predictor of growth in risky college drinking.
19410445 - Searching quality data for municipal solid waste planning.
20036115 - Estimation of the annual production and composition of c&d debris in galicia (spain).
21230515 - Biodiversity on island chains: neutral model simulations.
21162115 - Non-linear mixed effect modeling of the time-variant disposition of erythropoietin in a...
2674025 - A model-based system to determine the relative value of different variables in a diagno...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug development and industrial pharmacy     Volume:  24     ISSN:  0363-9045     ISO Abbreviation:  Drug Dev Ind Pharm     Publication Date:  1998 Apr 
Date Detail:
Created Date:  1999-02-01     Completed Date:  1999-02-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7802620     Medline TA:  Drug Dev Ind Pharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  353-8     Citation Subset:  IM    
Affiliation:
Laboratory of Pharmaceutical Technology, University of Gent, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Delayed-Action Preparations
Drug Compounding / instrumentation,  methods*
Evaluation Studies as Topic
Humans
Ibuprofen / administration & dosage
Starch
Theophylline / administration & dosage
Waxes
Chemical
Reg. No./Substance:
0/Delayed-Action Preparations; 0/Waxes; 15687-27-1/Ibuprofen; 58-55-9/Theophylline; 9005-25-8/Starch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a ...
Next Document:  Alternative solvent-free preparation methods for felodipine surface solid dispersions.